Evidence map›Paper›PMID 38905941›Full record

Trial reportThe International journal on drug policy2024

Safer-use strategies in the context of harm-reduction treatment for people experiencing homelessness and alcohol use disorder.

Yasmeen T Alawadhi, Emma Shinagawa, Emily M Taylor, Courtney Jackson, Andrew Fragasso, Maisie Howard, Liying Fan, Elena Kolpikova, Sarika Karra, Tessa Frohe and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The International journal on drug policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yasmeen T AlawadhiUniversity of Washington, Seattle, WA, USA.
Emma ShinagawaUniversity of Washington, Seattle, WA, USA; Washington State University, Pullman, WA, USA. Electronic address: emma.shinagawa@wsu.edu.
Emily M TaylorUniversity of Washington, Seattle, WA, USA.
Courtney JacksonUniversity of Washington, Seattle, WA, USA.
Andrew FragassoUniversity of Washington, Seattle, WA, USA.
Maisie HowardUniversity of Washington, Seattle, WA, USA.
Liying FanUniversity of Washington, Seattle, WA, USA.
Elena KolpikovaUniversity of Washington, Seattle, WA, USA.
Sarika KarraUniversity of Washington, Seattle, WA, USA.
Tessa FroheUniversity of Washington, Seattle, WA, USA.
Seema L ClifasefiUniversity of Washington, Seattle, WA, USA.
Mark H DuncanUniversity of Washington, Seattle, WA, USA.
Susan E CollinsUniversity of Washington, Seattle, WA, USA; Washington State University, Pullman, WA, USA.

Funding

Harm reduction with pharmacotherapy for homeless adults with alcohol dependenceR01AA022309 · NIAAA · UNIVERSITY OF WASHINGTON · PI COLLINS, SUSAN E · 2013 to 2017
$3.3M
eHaRT-A: Adapting an evidence-based, in-person harm reduction treatment into a virtual care telehealth intervention for people with lived experience of homelessness and alcohol use disorderK01AA030053 · NIAAA · UNIVERSITY OF WASHINGTON · PI Tessa Marie Frohe · 2022 to 2026
$861k
Harm-reduction treatment for homeless adults with alcohol-use disorders (HaRT-A)R34AA022077 · NIAAA · UNIVERSITY OF WASHINGTON · PI COLLINS, SUSAN E · 2014 to 2016
$662k
NIAAA NIH HHS K01 AA030053NIAAA NIH HHS R01 AA022309NIAAA NIH HHS R34 AA022077
6 · The paper itself

Abstract

backgroundTwo, randomized controlled trials found harm-reduction treatment for AUD (HaRT-A) improves alcohol outcomes for adults experiencing homelessness. HaRT-A, which neither requires nor precludes abstinence, entails tracking alcohol-related harm, harm-reduction goals, and safer-use strategies. This secondary dual study qualitatively describes this last component, safer-use strategies, and their quantitative association with treatment outcomes.

methodsParticipants were people who experienced homelessness and AUD and were enrolled in the active HaRT-A treatment arms in 2 randomized control trials (Trial 1 N = 86; Trial 2 N = 208). Trial 1was a 2-arm study with randomization to HaRT-A or services as usual. Trial 2 was a 4-arm study combining HaRT-A and extended release naltrexone. In HaRT-A sessions, participants received a list of 3 categories of safer-use strategies (i.e., buffering alcohol's effects on the body, changing the manner of drinking to be safer and healthier, and reducing alcohol use). Mixed methods were used to qualitatively describe safer-use strategies implemented and quantitatively test their association with alcohol outcomes (i.e., peak quantity, frequency, alcohol-related harm).

resultsIn Trial 1, but not Trial 2, participants committed to more safer-use strategies across time, which was associated with reductions in alcohol frequency over the past 30 days. In both trials, participants committing to reducing alcohol consumption drank on a quarter fewer days overall, and in Trial 2, experienced 15 % less alcohol-related harm. In Trial 1, participants who committed to changing the manner of drinking were heavier drinkers overall, and although they showed significant reductions in alcohol-related harm, their reduction rate was slower than for participants who selected other strategies. In Trial 2, strategies to buffer alcohol's effects were associated with a monthly 14 % decrease of alcohol-related harm.

conclusionThis study replicated prior findings that people experiencing homelessness and AUD regularly adopt strategies to reduce alcohol-related harm. The implementation of safer-use strategies was favorably associated with alcohol outcomes, but specific associations differed by trial and outcome. Discussion of safer-use strategies appears helpful; however, further research is needed to firmly establish how this HaRT-A component works.

Indexed as

AlcoholismHarm ReductionIll-Housed PersonsAdultAlcohol DrinkingFemaleHumansMaleMiddle AgedNaltrexoneTreatment OutcomeNaltrexoneAlcohol useAlcohol use disorderHarm reductionHomelessnessSafer-use strategies

Identifiers

PMID38905941
PMCPMC11305899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.